| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Trauma and Neurosurgery Intensive Care Unit, Department of Anaesthesia, St Michael's Hospital, Toronto, Ontario, Canada.
Address correspondence to: Dr. Andrew Baker, Department of Anaesthesia, St Michael's Hospital, 30 Bond Street, Toronto, Ontario M5B 1W8, Canada. Phone: 416-864-5510; Fax: 416-864-5512; E-mail: bakera{at}smh.toronto.on.ca
| Abstract |
|---|
|
|
|---|
Source: This narrative review is based on a selection of current literature on SjVO2 monitoring in conjunction with local experience using this technique.
Principal findings: Despite limitations, the use of SjVO2 monitoring has the potential to impact on patient care in the NICU. The placement of the catheter is relatively simple. Studies have confirmed that abnormalities in cerebral venous oxygen saturation are associated with adverse outcome following traumatic brain injury. There is evidence that SjVO2 may be a useful adjunct to ICP monitoring of patients with intracranial hypertension. Furthermore, managing cerebral extraction of oxygen in conjunction with cerebral perfusion pressure may result in an improved outcome. Further research in this area is needed. Other indications for SjVO2 monitoring include subarachnoid hemorrhage, cardiopulmonary bypass and following ischemic stroke.
Conclusion: In the past, the management of severe acute brain injury was targeted at ICP and perfusion pressure with little consideration for the metabolic requirements of the injured brain. SjVO2 monitoring is another tool the intensivist can use to obtain information about the global oxygen requirements of the injured brain on a continuous basis. Whether this will impact on care in the long term remains to be seen.
| Introduction |
|---|
|
|
|---|
| Pathophysiology of SjVO2 monitoring |
|---|
|
|
|---|
By the Fick principle cerebral oxygen consumption can be calculated:
![]() |
![]() |
As dissolved oxygen is negligible and can be ignored and since hemoglobin is constant, the content of oxygen is really proportional to the saturation and therefore the difference in arterial-venous (A-v) content of blood can be determined by the difference in SaO2 and SjVO2.
SjVO2 is therefore a function of the arterial oxygen saturation, CBF and CMRO2. In the situation where CMRO2 increases without a concomitant increase in CBF, the A-vO2 difference will rise in conjunction with cerebral oxygen extraction. This leads to a decrease in oxygen content or saturation of the venous effluent from the brain. As long as hemoglobin and arterial saturation remain constant, the SjVO2 is an indicator of cerebral oxygen demand.2
| SjVO2 catheter |
|---|
|
|
|---|
As the flow in the jugular veins is not the same, it would seem logical to insert the catheter into the vein with the greatest flow. There are several methods by which this can be accomplished. The first is purely functional where each jugular vein is compressed in turn and the catheter inserted into the vein with the largest rise in ICP following this manoeuver.2 The second uses the admission computer tomography scan to assess the jugular foramina and assumes that the larger must have the greater flow.9 The third uses ultrasound to visualize the dominant vein. None of these procedures has been studied in a controlled way and there is no evidence that the side of insertion is associated with better clinical outcome. Some advocate inserting the catheters into the side of injury but this is controversial.9
Equipment
During the early 1900's, the jugular bulb was pierced directly to obtain cerebral venous oxygen saturation. Later, permanent catheters were inserted high in the internal jugular vein. This allowed repetitive sampling of SjVO2 without repeated needle punctures. More recently, fibreoptic technology has allowed the development of in vivo spectrophotometric catheters. The catheters commonly available in North America include the Oximetrix 3® system from Abbott Laboratories (Illinois, USA) and the Edslab system from Baxter Healthcare® (Irvine, California, USA).10 Although the systems are similar, the Oximetrix 3 has the advantage of using three light wavelengths allowing measurement of both the hemoglobin concentration and oxygen saturation. With the Edslab system, the hemoglobin has to be entered manually. In general, both units appear to have equivalent sensitivity and specificity. Although the Oximetrix 3 can be calibrated prior to insertion, it is recommended that they undergo in vivo calibration at least daily and when the saturation readings are in question.
Catheter placement
The technique for retrograde cannulation of the internal jugular is relatively simple. The patient is positioned either horizontally or in a slight head down position. Care should be taken not to allow the ICP to increase above 20 mmHg. The internal jugular vein is cannulated in the cephalad direction, either distally between the heads of the sternocleidomastoid or more proximally, at the level of the cricoid ring. The Seldinger technique is used and a pediatric introducer with a luer lock adapter is inserted. The fibreoptic catheter is then advanced through the introducer to the jugular bulb, approximately at the level of the mastoid process.
Once the catheter is inserted, it is critical that the correct position be attained in order to limit the contamination from extra cerebral blood. Although, this is thought to represent only 3% of the blood in the jugular vein, there are anecdotal reports of far greater contamination.11 The catheter should sit as close to the roof of the jugular bulb as possible. Even a 2-cm difference can lead to as much as 10% contamination. This rises exponentially as the tip is withdrawn further. The position of the catheter tip can be confirmed by either a lateral or an antero-posterior (AP) neck radiograph.12 On the lateral film, the catheter tip must be above the disc of C1/C2 and as close to the skull base as possible (Figure 1
). On AP view, a correctly placed tip should lie cranial to a line extending from the atlanto-occipital joint space and caudal to the lower margin of the orbit. The catheter tip should also lie cranial to a line connecting the tips of the mastoid processes.
|
| Interpretation |
|---|
|
|
|---|
Normal values
Studies in healthy individuals suggest that normal SjVO2 values range somewhere between 55% and 71%.20,21 This is lower than mixed venous oxygen saturation and reflects the increased oxygen requirements of the normal brain. Whether this is true for patients with cerebral injury is not clear. Healthy volunteers are able to tolerate fairly low levels of venous oxygen saturation before neurological deficits become apparent. This is not the case in patients with head injury in who desaturation is associated with a worsened outcome.19,20 In fact, a single episode of desaturation below 50% is associated with a doubling of the mortality rate.21 Even in patients undergoing elective cardiovascular surgery, venous oxygen saturations below 50% are associated with an increase in the incidence of neurological complications.22 Current recommendations are to maintain the SjVO2 between 55% and 75% to allow for a margin of error.
The accuracy of SjVO2 measurement may be affected by a variety of factors including hemoglobin concentration, systemic arterial oxygen saturation, core temperature and CO2 levels. For this reason, many now use other measures of oxygen utilization to complement SjVO2.2 These include the cerebral arterial-venous oxygen saturation difference and lactate-oxygen index. The latter has been used extensively in the study of cerebral metabolism.10
Decreasing SjVO2 (Figure 2
)
A decrease in the SjVO2 represents an increase in cerebral oxygen extraction. In acute brain injury, this may result from systemic hypoxia, low CBF secondary to hypotension or vasospasm or increased ICP with a subsequent decrease in CPP.5,23 Factors that increase cerebral oxygen demand such as seizures or pyrexia may also play a role. In the setting of decreased SjVO2, it is necessary to determine which of the above play a role and to treat accordingly.24 In a study of over 100 patients admitted to an intensive care unit after traumatic brain injury (TBI), Gopinath et al. demonstrated that multiple episodes of low SjVO2 were associated with poorer outcomes than patients who had only one or no desaturations.20
|
| Clinical applications |
|---|
|
|
|---|
In addition to confirming the deleterious effects of low CPP, SjVO2 can be used to monitor interventional therapies. The use of mannitol is common in the setting of cerebral edema and raised ICP.28 There is some evidence that mannitol may initially reduce cerebral oxygenation. This can be detected by the use of the SjVO2 monitor. Hyperventilation has been used to rapidly decrease ICP in patients with intractable intracranial hypertension. The danger exists that the PaCO2 is decreased to the point where cerebral oxygenation may be compromised. Indeed, the Brain Trauma Foundation recommends maintaining PaCO2 between 3035 mmHg.29 Approximately 20% of patients with intracranial hypertension have a mismatch of CBF to metabolism where blood flow outstrips cerebral metabolic requirements. Hyperventilation in this group may lower blood flow and improve intracranial hypertension. Cruz investigated this so-called flow-metabolism coupling. In a study of 353 adults with severe acute brain injury, he compared therapies directed at cerebral extraction of oxygen and CPP as compared to management of CPP alone. The study demonstrated a significantly better outcome in the cerebral oxygen extraction group as compared to controls.30 SjVO2 monitoring is able to assist in identifying the threshold where further reductions in PaCO2 could lead to cerebral ischemia.31
Due to the lack of well-designed controlled trials, treatment management of TBI often depends on the philosophy of individual centres.32 The Brain Trauma Foundation Guidelines do not review the use of the SjVO2 monitor, but there is a suggestion that this technique may be useful in guiding second tier therapy in cases of refractory ICP.29 The European Brain Injury Consortium guidelines do not review the SjVO2 monitor33 and the Italian Society for Anaesthesia, Analgesia, Reanimation and Intensive Care provide suggested criteria for its use.34 Despite this lack of consensus, many centres in North America and abroad routinely insert these catheters.5,35
Other
More recently, the use of SjVO2 monitors during cardiac surgery with cardiopulmonary bypass has been explored.36 Although the SjVO2 does not change during the initiation phase of normothermic CPB, the potential for marked desaturation is present during the rewarming phase.37 Desaturation appears to be associated with low MAP, low hematocrit and rapid rewarming. It is now possible to assess the influence of the various warming and cooling techniques on cerebral oxygenation.38 Although the optimum level of SjVO2 in this group is unclear, several studies have indicated that a saturation of less then 50% is associated with increased mortality and poor neurological outcome.39 It should be noted that it has yet to be shown whether the catheters used for continuous monitoring are accurate at low temperatures (< 32°C).40
SjVO2 has been measured after cardiac arrest and an association found between high saturations and death.41 Whether this reflects the inability of the neurons to extract oxygen is not known. SjVO2 monitoring following subarachnoid hemorrhage is under investigation.42 The use of TCD to diagnose vasospasm has become fairly commonplace. One of the difficulties with the TCD is distinguishing hyperemia from vasospasm.43 The management of these two conditions is markedly different. The SjVO2 may be used in this setting, as patients with hyperemia would demonstrate markedly increased venous oxygen saturation while in severe vasospasm, the saturation would be decreased. There is no outcome data for this technique.
| Conclusion |
|---|
|
|
|---|
Revision received March 13, 2002. Accepted for publication December 7, 2002.
| References |
|---|
|
|
|---|
2 Feldman Z, Robertson CS. Monitoring of cerebral hemodynamics with jugular bulb catheters. Crit Care Clin 1997; 13: 5177.[Medline]
3 Hatiboglu MT, Anil A. Structural variations in the jugular foramen of the human skull. J Anat 1992; 180: 1916.
4 Lam JMK, Chan MSY, Poon WS. Cerebral venous oxygen saturation monitoring: is dominant jugular bulb cannulation good enough? Br J Neurosurg 1996; 10: 35764.[Medline]
5 van den Brink WA, van Santbrink H, Avezaat CJJ, et al. Monitoring brain oxygen tension in severe head injury: the Rotterdam experience. Acta Neurochir Suppl 1998; 71: 1904.[Medline]
6 Metz C, Holzschuh M, Bein T, Kallenbach B, Taeger K. Jugular bulb monitoring of cerebral oxygen metabolism in severe head injury: accuracy of unilateral measurements. Acta Neurochir Suppl 1998; 71: 3247.[Medline]
7 Komiyama M, Kan M, Shigemoto T, Kaji A. Marked regional heterogeneity in venous oxygen saturation in severe head injury studied by superselective intracranial venous sampling: case report. Neurosurgery 1999; 45: 146972.[Medline]
8
Schell RM, Cole DJ. Cerebral monitoring: jugular venous oximetry. Anesth Analg 2000; 90: 55966.
9 Stocchetti N, Paparella A, Bridelli F, Bacchi M, Piazza P, Zuccoli P. Cerebral venous oxygen saturation studied with bilateral samples in the internal jugular veins clinical study. Neurosurgery 1994; 34: 3843.[Medline]
10 Macmillan CSA, Andrews PJD. Cerebrovenous oxygen saturation monitoring: practical considerations and clinical relevance. Intensive Care Med 2000; 26: 102836.[Medline]
11 Matta BF, Lam AM. The rate of blood withdrawal affects the accuracy of jugular venous bulb. Oxygen saturation measurements. Anesthesiology 1997; 86: 8068.[Medline]
12 Bankier AA, Fleischmann D, Windisch A, et al. Position of jugular oxygen saturation catheter in patients with head trauma: assessment by use of plain films. Am J Roentgenol 1995; 16: 43741.
13 Lewis SB, Myburgh JA, Thornton EL, Reilly PL. Cerebral oxygenation monitoring by near-infrared spectroscopy is not clinically useful in patients with severe closed-head injury. A comparison with jugular venous bulb oximetry. Crit Care Med 1996; 24: 13348.[Medline]
14 Gopinath SP, Valadka AB, Uzura M, Robertson CS. Comparison of jugular venous oxygen saturation and brain tissue PO2 as monitors of cerebral ischemia after head injury. Crit Care Med 1999; 27: 233745.[Medline]
15
Gupta AK, Hutchinson PJ, Al-Rawi P, et al. Measuring brain tissue oxygenation compared with jugular venous oxygen saturation for monitoring cerebral oxygenation after traumatic brain injury. Anesth Analg 1999; 88: 54953.
16 Bardt TF, Unterberg AW, Kiening KL, Schneider G-H, Lanksch WR. Multimodal cerebral monitoring in comatose head-injured patients. Acta Neurochir (Wien) 1998; 140: 35765.[Medline]
17 Unterberg AW, Kiening KL, Hartl R, Bardt T, Sarrafzadeh AS, Lanksch WR. Multimodal monitoring in patients with head injury: evaluation of the effects of treatment on cerebral oxygenation. J Trauma 1997; 42(5S): S327.[Medline]
18 Jünger EC, Newell DW, Grant GA, et al. Cerebral autoregulation following minor head injury. J Neurosurg 1997; 86: 42532.[Medline]
19 De Deyne C, Decruyenaere J, Calle P, et al. Analysis of very early jugular bulb oximetry data after severe head injury: implications for the emergency management? Eur J Emerg Med 1996; 3: 6972.[Medline]
20 Gopinath SP, Robertson CS, Contant CF, et al. Jugular venous desaturation and outcome after head injury. J Neurol Neurosurg Psychiatry 1994; 57: 71723.[Abstract]
21 Sheinberg M, Kanter MJ, Robertson CS, Contant CF, Narayan RK, Grossman RG. Continuous monitoring of jugular venous oxygen saturation in head-injured patients. J Neurosurg 1992; 76: 2127.[Medline]
22 Chen C-S, Leu B-K, Liu K. Detection of cerebral desaturation during cardiopulmonary bypass by cerebral oximetry. Acta Anaesthesiol Sin 1996; 34: 1738.[Medline]
23 Dearden NM. Mechanisms and prevention of secondary brain damage during intensive care. Clin Neuropathol 1998; 17: 2218.[Medline]
24 Artru F, Jourdan C, Perret-Liaudet A, Charlot M, Mottolese C. Low brain tissue oxygen pressure: incidence and corrective therapies. Neurol Res 1998; 20(Suppl 1): S4851.
25 Cormio M, Valadka AB, Robertson CS. Elevated jugular venous oxygen saturation after severe head injury. J Neurosurg 1999; 90: 915.[Medline]
26 Vigué B, Ract C, Benayed M, et al. Early SjvO2 monitoring in patients with severe brain trauma. Intensive Care Med 1999; 25: 44551.[Medline]
27 Fandino J, Stocker R, Prokop S, Trentz O, Imhof H-G. Cerebral oxygenation and systemic trauma related factors determining neurological outcome after brain injury. J Clin Neurosci 2000; 7: 22633.[Medline]
28 Schneider G-H, von Helden A, Lanksch WR, Unterberg A. Continuous monitoring of jugular bulb oxygen saturation in comatose patients therapeutic implications. Acta Neurochir (Wien) 1995; 134: 715.[Medline]
29 The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Management and Prognosis of Severe Traumatic Brain Injury: Part 1: Guidelines for the management of severe traumatic brain injury. J Neurotrauma 2000; 17(6/7): 449554.
30 Cruz J. The first decade of continuous monitoring of jugular bulb oxyhemoglobinsaturation: management strategies and clinical outcome. Crit Care Med 1998; 26: 34451.[Medline]
31 Schaffranietz L, Heinke W. The effect of different ventilation regimes on jugular venous oxygen saturation in elective neurosurgical patients. Neurol Res 1998; 20(Suppl 1): S6670.
32 Basso A, Previgliano I, Duarte JM, Ferrari N. Advances in management of neurosurgical trauma in different continents. World J Surg 2001; 25: 11748.[Medline]
33 Maas AIR, Dearden M, Teasdale GM, et al., on behalf of the European Brain Injury Consortium. EBIC- guidelines for management of severe head injury in adults.. Acta Neurochir (Wien) 1997; 139: 28694.[Medline]
34 Procaccio F, Stocchetti N, Citerio G, et al. Guidelines for the treatment of adults with severe head trauma (part I). Initial assessment; evaluation and pre-hospital treatment; current criteria for hospital admission; systemic and cerebral monitoring. J Neurosurg Sci 2000; 44: 110.[Medline]
35 Kay A, Teasdale G. Head injury in the United Kingdom. World J Surg 2001; 25: 121020.[Medline]
36 Anastasiou E, Gerolioliou K, Karakoulas K, Peftoulidou M, Giala M. Reliability of continuous jugular venous bulb hemoglobin oxygen saturation during cardiac surgery. J Cardiothorac Vasc Anesth 1999; 13: 2769.[Medline]
37
Souter MJ, Andrews PJD, Alston RP. Jugular venous desaturation following cardiac surgery. Br J Anaesth 1998; 81: 23941.
38
Mutch WAC, Warrian RK, Eschun GM, et al. Biologically variable pulsation improves jugular venous oxygen saturation during rewarming. Ann Thorac Surg 2000; 69: 4917.
39 Croughwell ND, Newman MF, Blumenthal JA, et al. Jugular bulb saturation and cognitive dysfunction after cardiopulmonary bypass. Ann Thorac Surg 1994; 58: 17028.[Abstract]
40 Trubiano P, Heyer EJ, Adams DC, et al. Jugular venous bulb oxyhemoglobin saturation during cardiac surgery: accuracy and reliability using a continuous monitor. Anesth Analg 1996; 82: 9648.[Abstract]
41 Buunk G, van der Hoeven JG, Meinders AE. Prognostic significance of the difference between mixed venous and jugular bulb oxygen saturation in comatose patients resuscitated from a cardiac arrest. Resuscitation 1999; 41: 25762.[Medline]
42 Citerio G, Cormio M, Portella G, Vascotto E, Galli D, Gaini SM. Jugular saturation (SjvO2) monitoring in subarachnoid hemorrhage (SAH). Acta Neurochir Suppl 1998; 71: 3169.[Medline]
43 Manno EM. Transcranial Doppler ultrasonography in the neurocritical care unit. Crit Care Clin 1997; 13: 79104.[Medline]
44 Jones PA, Andrews PJD, Midgley S, et al. Measuring the burden of secondary insults in head-injured patients during intensive care. J Neurosurg Anesthesiol 1994; 6: 414.[Medline]
This article has been cited by other articles:
![]() |
K. Pattinson, G. Wynne-Jones, and C. H. Imray Monitoring intracranial pressure, perfusion and metabolism CEACCP, August 1, 2005; 5(4): 130 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Inoue, M. Kawaguchi, H. Furuya, and T. Sakaki Antecubital approach for monitoring jugular bulb venous oxygen saturation during carotid endarterectomy Can J Anesth, June 1, 2005; 52(6): 656 - 657. [Full Text] [PDF] |
||||
![]() |
A. D. McLeod, F. Igielman, C. Elwell, M. Cope, and M. Smith Measuring Cerebral Oxygenation During Normobaric Hyperoxia: A Comparison of Tissue Microprobes, Near-Infrared Spectroscopy, and Jugular Venous Oximetry in Head Injury Anesth. Analg., September 1, 2003; 97(3): 851 - 856. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |